Afghanistan vs Nepal: The number of people with susceptibility test result for rifampicin
Afghanistan
17,443
in 2021
Nepal
11,863
in 2021
Afghanistan rank
16th
Nepal rank
19th
The number of people with susceptibility test result for rifampicin over time
- Afghanistan
- Nepal
How they compare
Afghanistan currently reports 17,443 against 11,863 in Nepal, a difference of 5,580.
That makes Afghanistan's figure about 1.5 times Nepal's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Afghanistan ahead.
Afghanistan ranks 16th and Nepal ranks 19th of 155 countries.
Across the 2 decades both report, Afghanistan averaged higher in 1 and Nepal in 1.
Head to head by decade
| Decade | Afghanistan | Nepal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6,121 | 6,955 | 834 | Nepal |
| 2020s | 13,849 | 9,999 | 3,850 | Afghanistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Afghanistan or Nepal?
- Afghanistan, at 17,443 against 11,863 in Nepal as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Afghanistan and Nepal?
- 5,580, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Nepal?
- 5 years are reported by both, from 2017 to 2021.
- How do Afghanistan and Nepal rank globally for the number of people with susceptibility test result for rifampicin?
- Afghanistan ranks 16th and Nepal ranks 19th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.